camptothecin has been researched along with 1,2-dipalmitoylphosphatidylcholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daoud, SS; Fetouh, MI; Giovanella, BC | 1 |
| Lundberg, BB | 1 |
2 other study(ies) available for camptothecin and 1,2-dipalmitoylphosphatidylcholine
| Article | Year |
|---|---|
Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Breast Neoplasms; Camptothecin; Carcinoma; Cholesterol; Drug Carriers; Drug Evaluation, Preclinical; Humans; Liposomes; Melanoma, Experimental; Mice; Mice, Nude; Molecular Structure; Neoplasm Proteins; Neoplasm Transplantation; Phosphatidylinositols; Remission Induction; Skin Neoplasms; Sphingomyelins; Topoisomerase I Inhibitors | 1995 |
Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Survival; Drug Carriers; Emulsions; Humans; Lipid Bilayers; Liposomes; Solubility; Spectrometry, Fluorescence; Tumor Cells, Cultured | 1998 |